Document is current
Any future updates will be listed below
-
Authors
Poletti, Barbara https://orcid.org/0000-0003-4398-2051
Aiello, Edoardo Nicolò
Consonni, Monica
Iazzolino, Barbara
Torre, Silvia
Solca, Federica
Faltracco, Veronica
Telesca, Alessandra
Palumbo, Francesca
Dalla Bella, Eleonora
Bersano, Enrica
Riva, Nilo
Verde, Federico
Messina, Stefano
Doretti, Alberto
Maranzano, Alessio
Morelli, Claudia
Calvo, Andrea
Silani, Vincenzo
Lauria, Giuseppe
Chiò, Adriano
Ticozzi, Nicola
-
Funding
Funding for this research was provided by:
Fondazione Regionale per la Ricerca Biomedica
Fondo Europeo di Sviluppo Regionale
Ministero della Salute
Horizon 2020
Ministero dell’Istruzione, dell’Università e della Ricerca
- License Information
-
More Information
Article History
Received: 28 July 2024
Revised: 20 August 2024
Accepted: 20 August 2024
First Online: 5 September 2024
Declarations
:
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i>. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. B.P. is Associate Editor for <i>Frontier in Neuroscience</i>. N. T. received compensation for consulting services and/or speaking fees from Amylyx Pharmaceuticals, Biogen, Italfarmaco, and Zambon Biotech SA. He is Associate Editor for <i>Frontiers in Aging Neuroscience</i>. F.V. is Associated Editor for <i>Journal of Alzheimer’s Disease</i>. E.N.A. serves as an Editorial Board Member for <i>BMC Neurology</i>. A.Ch. is a member of the following Scientific Advisory Boards: Mitsubishi Tanabe, Roche, Biogen, Denali Pharma, Cytokinetics, Amylyx Pharmaceuticals, VectorY, and Ferrer and Zambon Biotech; he received a scientific grant from Biogen; he is a member of the following Drug Safety and Monitoring Boards: AB Science, Verge, Corcept and Eli Lilly; A. Ca. has received a research grant from Cytokinetics. The other authors have nothing to declare.
: Participants provided informed consent and data were treated according to current regulations. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (ID: 2013_06_25), by the Ethics Committee of Fondazione IRCCS Istituto Neurologico Carlo Besta (ID: 71/2015; 2017/06/07, Excerpt 6/41; 2020/06/17, Excerpt 01/73; 2023/01/18, Excerpt 06/11), and by the Ethics Committee of the ALS Expert Center of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza (ID: #0038876).
: Not applicable.
